ADO 0.00% 2.0¢ anteotech ltd

Ann: Test Platform and COVID-19 Test receive CE Mark approval, page-330

  1. 19 Posts.
    lightbulb Created with Sketch. 24
    Hi Charles89,

    I agree with the LFT/ART approach which will promotes results to testing being known quicker as long as there high sensitivity (which EuGeni can deliver).

    With regards the 3% of people getting missed, I think it’s important to highlight that figure relates to those who are positive cases. Imo if 10,000 people attend a concert and the prevalence of COVID-19 is 2% or less within that city’s population, you could then assume that 200 people have COVID-19. If everyone is tested we could assume that the “3% of people being missed” would total 6 people out of 10,000. Of those 6 missed, some may not be infectious, all 6 may not be infectious.

    I hope the example I’ve given makes sense and has some merit.

    aimho

    GLTAH
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.000(0.00%)
Mkt cap ! $49.37M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 100000 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 604706 5
View Market Depth
Last trade - 07.31am 16/08/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.